Series
Gastrointestinal
Status
Published
Date
Number of report
073
Endoscopic biliary procedures
Ask the expert
The report presents a summary of reimbursement situation for a number of diagnostic and therapeutic endoscopic biliary procedures in Europe, including:
- Endoscopic retrograde cholangiopancreatography (with or without biopsy)
- Peroral cholangioscopy (with or without biopsy)
- Endoscopic sphincterotomy of sphincter of Oddi
- Endoscopic retrograde insertion of stent into bile duct
- Endoscopic retrograde insertion of tubal prosthesis into bile duct
- Endoscopic retrograde extraction of calculus from bile duct
- Endoscopic dilation of bile duct
- Endoscopic retrograde lithotripsy of calculus of bile duct
- Endoscopic retrograde photodynamic laser therapy of lesion of bile duct
Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations).
The following indications will be considered depending on the type of procedure:
- cholangitis;
- cholelithiasis;
- cholangiocarcinoma.
The report will cover different types of settings.
The only reimbursement within public / statutory health insurance systems is considered. The results will be provided for hospital settings.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- France
- Germany
- Italy
- Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of treatment of endoscopic biliary procedures:
- Boston Scientific (SpyGlass, Extractor)
- Cook Medical (Common Bile Duct Exploration Set)
- ConMed (Gore Viabil, Fit, TruPass, ACE)
- Innovex Medical (Balloon Dilation Catheter)
- ISOMed (ISOMed)
- Edwards Lifesciences (Fogarty, Fogarty irrigation catheter, Cholangiography catheter)
- Envaste Limited (Maohe)
- Fujifilm (Double-Balloon)
- Karl Storz (Silver Scope, HyDome)
- Medtronic (biliary stent - Protege)
- Olympus (CHF-BP30)
- Pentax Medical (FCP‑9P)
- Polydiagnost (PolyScope)
- Stryker (Pinpoint)
- Teleflex Medical OEM (Dilatation catheter)
Table of content is not available at the moment. Report is still ongoing.
16
Mar 2023
In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.
Read more10
Mar 2023
In February 2023, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (transvenous obliteration for gastric varices, biodegradable spacer to reduce rectal toxicity during radiotherapy for prostate cancer), one new Health Technology Evaluation (guided self-help digital cognitive behavioural therapy), and two new Medtech Innovation Briefings (LIVERFASt, and Ambu aScope 4 RhinoLaryngo). Also, one new clinical guideline was published, and one was updated.
Read more08
Mar 2023
On February 23, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to preventing the family risk of colorectal carcinoma, shared decision-making in the hospitals, and digitally supported drug therapy management.
Read more23
Feb 2023
On February 1, 2023, the Treatment Council made its first two recommendations based on the major analysis reports regarding handheld focused ultrasound in emergency medicine and artificial intelligence as decision support for colonoscopy. The adoption of these technologies was not recommended.
Read more03
Feb 2023
On January 30, 2023, the Institute for the Hospital Remuneration System (InEK) published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2022. The medical technologies belonging to the cardiovascular, eHealth, gastrointestinal, neuromodulation, neurovascular, peripheral vascular, orthopedic, and other technology groups obtained positive status 1.
Read more